Biogen’s Pipeline: Alzheimer’s Is In, Stroke Is Out

Shelves
Biogen is shelving some pipeline assets to prioritize investment. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip